Althoff FC, Neb H, Herrmann E, et al. Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysis. Ann Surg 2019; 269: 794-804.
Esper SA, Waters JH. Intra-operative cell salvage: A fresh look at the indications and contraindications. Blood Transfus 2011; 9: 139-147.
George J, Sikora M, Masch J, et al. Infection Is Not a Risk Factor for Perioperative and Postoperative Blood Loss and Transfusion in Revision Total Hip Arthroplasty. J Arthroplasty 2017; 32: 214-219.e1.
Goel R, Patel EU, Cushing MM, et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American Registry. JAMA Surg 2018; 153: 826-833.
Greenky M, Shaner J, Rasouli MR, et al. Intraoperative Blood Salvage in Revision Total Hip Arthroplasty: Who Benefits Most? J Arthroplasty 2014; 29: 1298-1300.
Isbister JP. The three-pillar matrix of patient blood management-an overview. Best Pr Res Clin Anaesthesiol 2013; 27: 69-84.
Klein AA, Bailey CR, Charlton AJ, et al. Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018; 73: 1141-1150.
Kleinerüschkamp A, Meybohm P, Straub N, et al. A model-based cost-effectiveness analysis of Patient Blood Management. Blood Transfus 2019; 17: 16-26.
Kumar A, Mhaskar R, Grossman BJ, et al. T 1116 2015; 55: 1116-1127.
Kumar N, Zaw AS, Kantharajanna SB, et al. Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? Transfus Med 2017: 327-334.
Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57: 1347-1358.
Meybohm P, Herrmann E, Steinbicker AU, et al. Patient Blood Management is Associated with a Substantial Reduction of Red Blood Cell Utilization and Safe for Patient's Outcome: A Prospective, Multicenter Cohort Study with a Noninferiority Design. Ann Surg 2016; 264: 203-211.
Moretti VM, Post ZP. Surgical Approaches for Total Hip Arthroplasty. Indian J Orthop 2017; 51: 368-376.
Palmer AJR, Lloyd TD, Gibbs VN, et al. The role of intra-operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study. Anaesthesia 2020; 75: 479-486.
Rigal JC, Riche VP, Tching-Sin M, et al. Cost of red blood cell transfusion; evaluation in a French academic hospital. Transfus Clin Biol 2020; 27: 222-228.
Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311: 1317-1326.
Walsh TS, Palmer J, Watson D, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2012; 108: 63-71.
Shander A, Roy R. Postoperative Anemia: A Sign of Treatment Failure. Anesthesia & Analgesia 2016; 122 (6): 1755-1759.
Ackfeld T, Schmutz T, Guechi Y, et al. Blood Transfusion Reactions: A Comprehensive Review of the Literature including a Swiss Perspective. J Clin Med. 2022; 11: 2859.
Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012; 52: 1983-1988.
Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107: i41-i59.
